WITNESSES
Wednesday, December 6, 1995 (Meeting No. 19)
AIDS Coalition of Nova Scotia:
James Shedden, Men's Project Co-ordinator.
Burlington Breast Cancer Support Group:
Pat Kelly, Member.
Canadian Breast Cancer Network:
Sharon Batt, Member.
Canadian Haemophilia Society:
Lorraine Parsons, Member, Ottawa Chapter.
COCQ-sida:
Lise Pinault, Director General.
As individuals:
Susan Conrad;
Ahmed Hassan;
Dr. Ken J. Logue;
Dr. Doug McFadden;
Dr. Christos Tsoukas.
Ottawa General Hospital:
Diane Fillion, Nursing Co-ordinator, AIDS Clinic.
Pharmaceutical Manufacturer's Association of Canada:
Dr. Sophia Fourie, Vice-President, Medical & Regulatory Affairs, Pharmacea and Upjohn, Inc.;
Dr. Michael D. Levy, Vice-President, Medical Sciences, Glaxo Wellcome;
William D. Milligan, Vice-President, Biomed Business Unit, Hoffmann La Roche.
Wellsley Health Centre:
Mary Grondin, Nursing Co-ordinator.
Thursday, December 7, 1995 (Meeting No. 20)
Canadian Association for HIV Research:
Dr. Mark Wainberg.
Community AIDS Treatment Information Exchange:
Dierdre MacLean, Community Liaison Coordinator.
COCQ-sida:
Lise Pinault, Coordinator;
Department of Health:
Dr. Jacques Bouchard, Acting Chief, AIDS and viral Diseases Division, Bureau of Human Prescription Drugs;
Beth Pieterson, Chief, Submission and Information Policy Division;
Dr. Tomasz Uscinowicz, Manager, Clinical Trials and Special Access Program, Drugs Directorate.
As individuals:
Dr. Ken Logue;
Dr. Doug MacFadden.
Nova Scotia Aids Coalition:
James Shedden.
Ottawa General Hospital:
Dr. Bill Cameron, Clinical Trials Network.
Pharmaceutical Manufacturers Association of Canada:
Dr. Sophia Fourie, Vice-President, Medical & Regulatory Affairs, Pharmacea and Upjohn, Inc.;
Dr. Michael Levy, Vice-President, Medical Sciences, Glaxo Wellcome;
William Milligan, Vice-President, Biomedical Business Unit, Hoffmann La Roche.
Wednesday, December 13, 1995 (Meeting No. 21)
B.C. People with AIDS:
Arn Schilder, Vice-Chair.
Canadian Cancer Society:
Dr. Neill Iscoe, President, Ontario Chapter.
Canadian HIV Trials Network:
Dr. Don Zarowny.
Faculty of Medecine, Dalhousie University:
Dr. John Ruedy, Dean.
As Individuals:
Dr. Sharon Walmsley;
John Dixon.
Justice Canada:
Mario Simard, Senior Legal Counsel, Legal Services - Health Canada.
McGill Centre for Medicine, Ethics and the Law:
Trudo Lemmens.
Medical Research Council of Canada:
Dr. Michel Denis, Scientific Officer.
National Council on Bioethics in Human Research:
Derek Jones, Director.
Pharmaceutical Manufacturers' Association of Canada:
Dr. Sophia Fourie, Vice-President, Medical & Regulatory Affairs, Pharmacea and Upjohn, Inc.;
Dr. Michael Levy, Vice-President, Medical Sciences, Glaxo Wellcome.
Thursday, December 14, 1995 (Meeting No. 22)
Access to Effective Cancer Care in Ontario:
Carol Harkness, Member.
B.C. People with AIDS:
Arn Schilder, Vice-chair.
Canadian HIV Trials Network:
Dr. Michael O'Shaughnessy, Director, B.C. Centre for Excellence in HIV/AIDS.
Canadian Life and Health Insurance Association:
Charles Black, Senior Advisor, Insurance Operations;
Gerry Byrne, Liberty Health, Member Company.
Health Canada:
Dr. Jacques Bouchard, Acting Chief, AIDS and viral Diseases Division, Bureau of Human Prescription Drugs;
Beth Pieterson, Chief, Submission and Information Policy Division.
As Individuals:
Dr. Robert Voigt;
Dr. Sharon Walmsley.
Ministry of Health, Government of Ontario:
Lance Payne, Drug Programs.
Pharmaceutical Manufacturers' Association of Canada:
Dr. Sophia Fourie, Vice-President, Medical & Regulatory Affairs, Pharmacea and Upjohn, Inc.;
Dr. Michael Levy, Vice-President, Medical Sciences, Glaxo Wellcome;
William Milligan, Vice-President, Biomedical Business Unit, Hoffmann La Roche.